太安堂(002433.SZ):上半年預虧1.25億元-1.45億元
格隆匯7月15日丨太安堂(002433.SZ)披露2022年半年度業績預吿,預計2022年半年度實現歸屬於上市公司股東的淨利潤為虧損1.25億元-1.45億元,上年同期為盈利5.20億元;扣除非經常性損益後的淨利潤為虧損1.26億元-1.46億元,上年同期為虧損1.35億元。業績變動原因系:
1、去年同期公司盈利5.20億元,主要系轉讓持有子公司廣東康愛多數字健康科技有限公司的47.35%股權產生的投資收益及喪失控制權後,剩餘股權按公允價值重新計量產生的利得。
2、因上述第1點原因,去年同期非經常損益對淨利潤的影響較大,影響金額6.55億元,導致該報吿期歸屬於上市公司股東的淨利潤與去年同期比較,下降幅度較大。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.